Life-style modification in peripheral arterial disease

被引:31
作者
Khan, S
Cleanthis, M
Smout, J
Flather, M
Stansby, G [1 ]
机构
[1] Freeman Rd Hosp, No Vasc Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Queen Elizabeth II Hosp, Dept Vasc Surg, Gateshead, England
[3] Royal Brompton Hosp, Clin Trials Unit, London SW3 6LY, England
关键词
peripheral arterial disease; exercise; diet; obesity; weight loss; smoking;
D O I
10.1016/j.ejvs.2004.09.020
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective. To review the published evidence supporting the use of life-style modification in peripheral arterial disease (PAD). Design. A systematic search of the medical literature zoos performed for relevant studies. Materials. The publications obtained were then searched for randomised clinical trials which reported end-points Of mortality or major cardiovascular event rates with various life-style modifications. Results. Only one randomised controlled trial was found reporting relevant end-points. Other trials were of other endpoints such as walking distance or biochemical markers. Conclusions. There is a lack of randomised controlled data proving the benefit of life-style modification in improving mortality and reducing cardiovascular events in patients with PAD. Despite this there is sufficient evidence to recommend some life-style modification as part of the overall approach to risk reduction in these patients. There is compelling evidence to support smoking cessation, increased exercise and improved diet.
引用
收藏
页码:2 / 9
页数:8
相关论文
共 120 条
  • [1] UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
    Adler, AI
    Stevens, RJ
    Neil, A
    Stratton, IM
    Boulton, AJM
    Holman, RR
    [J]. DIABETES CARE, 2002, 25 (05) : 894 - 899
  • [2] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [3] BAINTON D, 1994, BRIT HEART J, V72, P128
  • [4] Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy
    Benowitz, NL
    Gourlay, SG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) : 1422 - 1431
  • [5] BLOOM RJ, 1990, AM SURGEON, V56, P535
  • [6] Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
    Böger, RH
    Bode-Böger, SM
    Thiele, W
    Creutzig, A
    Alexander, K
    Fröhlich, JC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1336 - 1344
  • [7] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [8] EPIDEMIOLOGY OF INTERMITTENT CLAUDICATION IN MIDDLE-AGED MEN
    BOWLIN, SJ
    MEDALIE, JH
    FLOCKE, SA
    ZYZANSKI, SJ
    GOLDBOURT, U
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (05) : 418 - 430
  • [9] Factor determining cardiac hypertrophy in hypertensive patients with or without peripheral vascular disease
    Brahimi, M
    Levy, BI
    Safar, ME
    Dabiré, H
    [J]. CLINICAL SCIENCE, 1998, 95 (03) : 261 - 267
  • [10] DIABETES, INTERMITTENT CLAUDICATION, AND RISK OF CARDIOVASCULAR EVENTS - THE FRAMINGHAM-STUDY
    BRAND, FN
    ABBOTT, RD
    KANNEL, WB
    [J]. DIABETES, 1989, 38 (04) : 504 - 509